The case of KSR v Teleflex addressess the issue of obviousness, which is fundamental for the biotech industry in general, and especially for companies operating in the area of stem cells. This video clip overviews some aspects of the case. More details can be found in the StemCellPatents.com Journal Article entitled Obviousness and Biotechnology.
The oral arguements may be read hereSocial & Bookmarking: